ADVM vs. ARKK

Last updated Jun 3, 2026

ADVM (Adverum Biotechnologies, Inc.) is a stock, while ARKK (ARK Innovation ETF) is Technology Equities fund actively managed by ARK. Over the past 10 years, ADVM returned -20.75%/yr vs 16.01%/yr for ARKK. At a 0.35 correlation, their price movements are largely independent.

Performance

ADVM vs. ARKK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Adverum Biotechnologies, Inc. (ADVM) and ARK Innovation ETF (ARKK). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

Over the past 10 years, ADVM has underperformed ARKK with an annualized return of -20.75%, while ARKK has yielded a comparatively higher 16.01% annualized return.

ADVM

• 1D: 0.00%
• 1M: 0.00%
• YTD: 0.00%
• 6M: 4.81%
• 1Y: 79.42%
• 3Y*: -28.84%
• 5Y*: -33.61%
• 10Y*: -20.75%

ARKK

• 1D: -1.66%
• 1M: 3.89%
• YTD: 3.89%
• 6M: 2.16%
• 1Y: 39.87%
• 3Y*: 24.63%
• 5Y*: -5.49%
• 10Y*: 16.01%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ADVM vs. ARKK - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ADVM Adverum Biotechnologies, Inc.	0.00%	-6.64%	-37.96%	29.91%	-67.07%	-83.76%	-5.90%	265.71%	-10.00%	20.69%
ARKK ARK Innovation ETF	3.89%	35.49%	8.40%	69.04%	-66.97%	-23.60%	152.71%	35.08%	3.52%	87.33%

Correlation

The correlation between ADVM and ARKK is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.13
Correlation (3Y) Calculated over the trailing 3-year period	0.25
Correlation (5Y) Calculated over the trailing 5-year period	0.29
Correlation (10Y) Calculated over the trailing 10-year period	0.34
Correlation (All Time) Calculated using the full available price history since Jan 5, 2016	0.35

Over the past year, the correlation between ADVM and ARKK has dropped to 0.13 - well below their long-term average of 0.35, suggesting their price drivers have been diverging.

Return for Risk

ADVM vs. ARKK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ADVM

ADVM Risk / Return Rank: 68
ADVM Sharpe Ratio Rank: 81
ADVM Sortino Ratio Rank: 83
ADVM Omega Ratio Rank: 86
ADVM Calmar Ratio Rank: 47
ADVM Martin Ratio Rank: 46

ARKK

ARKK Risk / Return Rank: 28
ARKK Sharpe Ratio Rank: 30
ARKK Sortino Ratio Rank: 31
ARKK Omega Ratio Rank: 28
ARKK Calmar Ratio Rank: 27
ARKK Martin Ratio Rank: 23

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ADVM vs. ARKK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Adverum Biotechnologies, Inc. (ADVM) and ARK Innovation ETF (ARKK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ADVM	ARKK	Difference
Sharpe ratio Return per unit of total volatility	1.49	1.10	+0.39
Sortino ratio Return per unit of downside risk	2.57	1.67	+0.89
Omega ratio Gain probability vs. loss probability	1.38	1.19	+0.19
Calmar ratio Return relative to maximum drawdown	0.27	1.33	-1.07
Martin ratio Return relative to average drawdown	0.49	2.98	-2.49
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ADVM vs. ARKK - Sharpe Ratio Comparison

The current ADVM Sharpe Ratio is 1.49, which is higher than the ARKK Sharpe Ratio of 1.10. The chart below compares the historical Sharpe Ratios of ADVM and ARKK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ADVM	ARKK	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.49	1.10	+0.39
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.45	-0.12	-0.33
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.26	0.40	-0.66
Sharpe Ratio (All Time) Calculated using the full available price history	-0.31	0.35	-0.67

Drawdowns

ADVM vs. ARKK - Drawdown Comparison

The maximum ADVM drawdown since its inception was -99.20%, which is greater than ARKK's maximum drawdown of -80.97%. Use the drawdown chart below to compare losses from any high point for ADVM and ARKK.

Drawdown Indicators

	ADVM	ARKK	Difference
Max Drawdown Largest peak-to-trough decline	-99.20%	-80.97%	-18.23%
Max Drawdown (1Y) Largest decline over 1 year	-27.61%	-31.35%	+3.74%
Max Drawdown (3Y) Largest decline over 3 years	-92.70%	-39.56%	-53.14%
Max Drawdown (5Y) Largest decline over 5 years	-94.63%	-77.23%	-17.40%
Max Drawdown (10Y) Largest decline over 10 years	-99.20%	-80.97%	-18.23%
Current Drawdown Current decline from peak	-98.30%	-48.26%	-50.04%
Average Drawdown Average peak-to-trough decline	-69.71%	-30.11%	-39.60%
Ulcer Index Depth and duration of drawdowns from previous peaks	28.33%	14.03%	+14.30%

Volatility

ADVM vs. ARKK - Volatility Comparison

The current volatility for Adverum Biotechnologies, Inc. (ADVM) is 0.00%, while ARK Innovation ETF (ARKK) has a volatility of 9.30%. This indicates that ADVM experiences smaller price fluctuations and is considered to be less risky than ARKK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ADVM	ARKK	Difference
Volatility (1M) Calculated over the trailing 1-month period	0.00%	9.30%	-9.30%
Volatility (6M) Calculated over the trailing 6-month period	26.80%	25.13%	+1.67%
Volatility (1Y) Calculated over the trailing 1-year period	68.78%	36.31%	+32.47%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	76.85%	46.30%	+30.55%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	81.35%	40.27%	+41.08%

Dividends

ADVM vs. ARKK - Dividend Comparison

Neither ADVM nor ARKK has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ADVM Adverum Biotechnologies, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ARKK ARK Innovation ETF	0.00%	0.00%	0.00%	0.70%	0.00%	0.55%	1.64%	0.38%	3.14%	1.32%	0.00%	2.27%

Frequently Asked Questions

Can I hold both ADVM and ARKK in my portfolio?

ADVM and ARKK have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ADVM or ARKK?

ARKK has higher volatility (9.30%) compared to ADVM (0.00%). In terms of maximum drawdown, ADVM dropped -99.20% vs ARKK's -80.97%.

Which has better risk-adjusted returns?

ADVM currently has the higher Sharpe Ratio (1.49 vs 1.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.